Agency will require a Limitation of Use section in the prescribing information of all extended-release ADHD stimulants ...

Labels of all extended-release stimulants indicated for ADHD -- including certain formulations of amphetamine and ...

The U.S. Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants used to ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

The U.S. Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants to treat ...

Taking to platforms including Reddit and Telegram for guidance, buyers import small quantities, often described as research ...

The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...

These popular medications are now at the center of a major weight loss drug lawsuit. Find out which drugs and involved and ...

The Food and Drug Administration is revising the labeling of all extended-release stimulants used to treat attention-deficit ...